31,705 followers
@drajmackay @nav_doc @BisChakrabarti @US_FDA True.FEV1 poor surrogate marker.Urg need 2 consider PROs in COPD trials https://t.co/zuo5RvRqOx
@drajmackay @nav_doc @BisChakrabarti @US_FDA True.FEV1 poor surrogate marker.Urg need 2 consider PROs in COPD trials https://t.co/zuo5RvRqOx
@mc_hankins Physical function/ activity; breathlessness; QOL https://t.co/XtMCfIufvY
RT @JuanGrvas: Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement.COPD emotional, and mental well-being http://t.co/YeE8hFhz
Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement.COPD emotional, and mental well-being http://t.co/YeE8hFhz